Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nephro Care India Limited (NSE: NEPHROCARE), ISIN INE0SUN01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NEPHROCARE last traded at ₹78.35 (+0.97%), with a 52-week range of ₹50.05 to ₹156.35 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 61.71%, FIIs 0.73%, DIIs 0.86%, mutual funds 0.00%.
EquiSense Score (ECS): 77/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.